About
Diagnostics
Areas of Focus
Categories
Diagnostics
Clinical Trials (5)
View allTotal Trials
5
As Lead Sponsor
3
As Collaborator
2
Total Enrollment
2,748
By Status
COMPLETED: 3RECRUITING: 1UNKNOWN: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06652100Lead Sponsor
Establishment of ProNephro AKI (NGAL) Cut Off Value for Risk Assessment of Moderate to Severe Acute Kidney Injury in Adults
N/ARecruiting
800 participants
Started: Oct 28, 2024 · Completed: Jan 31, 2026
NCT04008810Collaborator
Serum Neutrophil Gelatinase-associated Lipocalins (NGAL) and Chronic Kidney Disease
N/ACompleted
1,032 participants
Started: Oct 3, 2019 · Completed: Jun 3, 2024
NCT03527160Collaborator
Assessment of Urinary NGAL to Predict AKI in Children Receiving Multiple Nephrotoxic Medications
N/ACompleted
134 participants
Started: Apr 23, 2018 · Completed: Jun 30, 2019
NCT03057457Lead Sponsor
The NGAL Test™ As An Aid in the Risk Assessment for AKI Stage II and III in an Intensive Care Population
N/AUnknown
530 participants
Started: Mar 31, 2017 · Completed: Feb 28, 2018
NCT02121470Lead Sponsor
NGAL As An Aid for the Diagnosis of Acute Kidney Injury in Intensive Care
N/ACompleted
252 participants
Started: Feb 28, 2014 · Completed: Jun 30, 2015
Locations (1)
Headquarters
Hellerup, Denmark
Map
Loading map...